title: Swedish registers to examine drug safety and clinical issues in RA.
abstract: Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.
authors.affiliation: Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden. johan.askling@ki.se
authors.forename: J
authors.initials: J
authors.lastname: Askling
authors.forename: C M
authors.initials: CM
authors.lastname: Fored
authors.forename: P
authors.initials: P
authors.lastname: Geborek
authors.forename: L T H
authors.initials: LT
authors.lastname: Jacobsson
authors.forename: R
authors.initials: R
authors.lastname: van Vollenhoven
authors.forename: N
authors.initials: N
authors.lastname: Feltelius
authors.forename: S
authors.initials: S
authors.lastname: Lindblad
authors.forename: L
authors.initials: L
authors.lastname: Klareskog
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004992:Ethics, Medical; D005500:Follow-Up Studies; D006801:Humans; D008498:Medical Record Linkage; D012042:Registries; D012449:Safety; D013548:Sweden; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents